BioMarin Pharmaceutical Inc.
BMRN
$58.58
$0.510.88%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 10.77% | -0.29% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 10.77% | -0.29% | |||
| Cost of Revenue | 0.36% | 127.92% | |||
| Gross Profit | 18.20% | -28.85% | |||
| SG&A Expenses | 12.69% | 20.69% | |||
| Depreciation & Amortization | -0.02% | -49.78% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.23% | 6.36% | |||
| Operating Income | 23.67% | -12.96% | |||
| Income Before Tax | 25.11% | 40.35% | |||
| Income Tax Expenses | 9.41% | 17.24% | |||
| Earnings from Continuing Operations | 29.54% | 48.62% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 29.54% | 48.62% | |||
| EBIT | 23.67% | -12.96% | |||
| EBITDA | 20.12% | -12.42% | |||
| EPS Basic | 28.91% | 48.40% | |||
| Normalized Basic EPS | 24.50% | -10.45% | |||
| EPS Diluted | 28.85% | 47.99% | |||
| Normalized Diluted EPS | 24.72% | -10.26% | |||
| Average Basic Shares Outstanding | 0.49% | 0.15% | |||
| Average Diluted Shares Outstanding | 0.31% | -0.05% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||